Finland said last week that they are awaiting a new review by the European Medicines Agency (EMA) to decide whether or not to incorporate it into the vaccination schedule.
The vaccination campaign will continue without the shot from the British-Swedish company, Danish Health Administration Soren Brostrom said at a press conference in Copenhagen on Wednesday.
EU regulators also acknowledged a link between unusual clotting and the coronavirus shot in "very rare" cases, but upheld their endorsement of the drug's use in all adults.
The drugmaker also noted that, according to the latest data, the vaccine was well-tolerated, and no safety concerns related to the vaccine were identified.
France, Italy, Latvia, Spain, Germany and Bulgaria announced they would restart vaccinations, while Sweden said it needs "a few days" to assess the report before lifting the ban.
Health Minister Jens Spahn said Germany had recorded seven cases of thrombosis in cerebral veins among 1.6 million vaccinations with the AstraZeneca jab.
Health authorities in Norway are now asking people under 50 who received the AstraZeneca shot in the last two weeks to watch out for any side effects of bleeding, and to go to a doctor if necessary.